Colorectal Cancer Diagnostics Market Growth Report | 2023-2028
[Research Report] The colorectal cancer diagnostics market size is expected to grow from US$ 10,374.68 million in 2022 to US$ 16,996.48 million by 2028; it is estimated to record a CAGR of 8.7% from 2023 to 2028.
The colorectal cancer diagnostics market is segmented based on modality, end user, and geography. The report offers insights and in-depth market analysis, emphasizing parameters such as drivers, trends, opportunities, and competitive landscape analysis of leading market players across various regions. It also includes analyses of the impact of the COVID-19 pandemic across major regions.
Market Insights
Launches of New Products Drives Colorectal
Major players in the colorectal cancer diagnostics market manufacture a wide range of devices that help reduce the burden of colorectal cancer and other associated indications such as colon polyps, Crohn’s disease, colitis, and irritable bowel syndrome. In July 2022, US Digestive Health (USDH), a network of top-rated gastrointestinal (GI) practices, announced the commercialization of AI-assisted colonoscopy screenings with the country’s largest installation of Genious Intelligent GI endoscopy modules. These modules are expected to help physicians identify hard-to-detect and potentially cancerous polyps in real time. With the launch of this device, patients throughout southeastern, southwestern, and central Pennsylvania can now access AI-assisted colonoscopy with enhanced capabilities. In September 2020, Olympus Corporation announced the launch of ENDO-AID, a cutting-edge platform powered by artificial intelligence (AI). The platform includes ENDO-AID CADe application (app), a computer-aided endoscopic method for the detection of different conditions of the colon. This new AI platform enables the real-time display of automatically detected suspicious lesions and works in combination with its EVIS X1. Thus, the frequent developments and new product launches drive the colorectal cancer diagnostics market growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Colorectal Cancer Diagnostics Market: Strategic Insights
Market Size Value in US$ 10,374.68 million in 2022 Market Size Value by US$ 16,996.48 million by 2028 Growth rate CAGR of 8.7% from 2023 to 2028 Forecast Period 2023-2028 Base Year 2023
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Colorectal Cancer Diagnostics Market: Strategic Insights
| Market Size Value in | US$ 10,374.68 million in 2022 |
| Market Size Value by | US$ 16,996.48 million by 2028 |
| Growth rate | CAGR of 8.7% from 2023 to 2028 |
| Forecast Period | 2023-2028 |
| Base Year | 2023 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Modality-Based Insights
Based on modality, the colorectal cancer diagnostics market is bifurcated into stool-based tests and imaging tests. In 2022, the imaging tests segment held a larger share of the colorectal cancer diagnostics market and is anticipated to register a higher CAGR during the forecast period. The use of imaging tests in colorectal cancer diagnostics has evolved over the last few years. Imaging results are instrumental in surveillance, diagnosis, staging, treatment selection, and follow-up scheduling. Imaging tests involve looking at the structure of the colon and rectum for the presence of any abnormal areas. Imaging examinations use scopes, tube-like instruments with a light and tiny video camera at their end, inserted into the rectum. These tests scan the inside of the colon and rectum for any abnormal areas that might be cancer or polyps. These tests are used less often than stool-based tests and require more preparation beforehand and have some associated risks, unlike stool-based tests. The imaging tests is further classified into colonoscopy, CT colonography, flexible sigmoidoscopy, capsule endoscopy, and others.
Colonoscopy segment held the largest share of the market in 2022. However, CT colonography is expected to grow at a faster pace during the forecast period. CT colonography aids in the morphological analysis of wall deformities, providing information required for the preoperative assessment of T staging in colorectal cancer. As per the guidelines of Response Evaluation Criteria in Solid Tumors (RECIST), CT is the most widely used modality for assessing treatment response in patients with metastasized colon and rectal tumors. The common advantages of CT colonography are as follows: it is quick and safe, it helps to visualize the entire colon, and no sedation is required to perform the test. This test is recommended to be performed every five years in asymptomatic patients with average risk.
End User-Based Insights
Based on end user, the colorectal cancer diagnostics market is segmented into hospitals, diagnostic laboratories, cancer research institutes, and others. The hospitals segment accounted for the largest market share in 2022 and is anticipated to register the highest CAGR during the forecast period.
The colorectal cancer diagnostics market players adopt organic strategies such as product launch and expansion to expand their geographic footprint and product portfolios and meet the growing demands. Inorganic growth strategies adopted by market players allow them to expand their businesses and enhance their geographic presence. Additionally, these growth strategies help companies strengthen their clientele and enlarge their product portfolios.
- In December 2022, Epigenomics licenses protein biomarker technology for blood-based colorectal cancer test. The company has licensed from The University of Texas MD Anderson Cancer Center certain patent and technology rights to biomarkers associated with colorectal cancer detection.
- In August 2021, Illumina Acquired GRAIL to Accelerate Patient Access to Life-Saving Multi-Cancer Early-Detection Test. GRAIL's Galleri blood test detects 50 different cancers before they are symptomatic. Illumina's acquisition of GRAIL will accelerate access and adoption of this life-saving test worldwide.
Colorectal Cancer Diagnostics Market Report Scope
Company Profiles
- Medtronic Plc
- Illumina Inc
- Clinical Genomics Technologies Pty Ltd
- EDP Biotech Corp
- Epigenomics AG
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Inc
- Novigenix SA
- Siemens Healthineers AG
- Bruker Corp
- Eiken Chemical Co., Ltd.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Modality, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Colorectal cancer diagnostics refers to the tools, kits and test performed on an individual to diagnose colorectal cancer in an individual. This involves series of non-invasive and invasive test to confirm the cancer and its stage based on that treatment will be provided to the patient.
Asia Pacific is expected to be the fastest growing region in the colorectal cancer diagnostics market. Asia Pacific registered as the fastest-growing region in the global colorectal cancer diagnostics market. The market in this region is driven due to rising incidences of colorectal cancer, easy access to the diagnosis for colorectal cancer, and proposing guidelines for the procedures. Also, increasing government funding for research activities in colorectal cancer is expected to propel the growth of the market for colorectal cancer diagnostics in Asia Pacific.
The colorectal cancer diagnostics market, based on modality, is bifurcated into imaging tests and stool based tests. In 2022, the imaging tests segment held the larger share and is expected to grow at a CAGR of 8.8% during the forecast period. Screening and imaging play a vital role in the diagnostics of colorectal cancer to understand the extent of tumor-affected area, that act as a major driving factor for the growth of the imaging tests segment.
The factors that are driving growth of the market are increasing prevalence of colorectal cancer and launches of new products.
The US holds the largest market share in colorectal cancer diagnostics market. The growth of the market in the country is because in 2022, more than 600,000 surgeries are performed annually in the US to treat colon diseases. According to the American Cancer Society, the 5-year survival rate for localized colon cancer is 91% and for localized rectal cancer is 90%.
The colorectal cancer diagnostics market majorly consists of the players such as Medtronic Plc, Illumina Inc, Clinical Genomics Technologies Pty Ltd, EDP Biotech Corp, Epigenomics AG, F Hoffmann-La Roche Ltd, Quest Diagnostics Inc, Novigenix SA, Siemens Healthineers AG, Bruker Corp, and Eiken Chemical Co Ltd.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Colorectal Cancer Diagnostics Market – by Modality
1.3.2 Global Colorectal Cancer Diagnostics Market – by End User
1.3.3 Global Colorectal Cancer Diagnostics Market – by Geography
2. Colorectal Cancer Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Colorectal Cancer Diagnostics Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 South and Central America PEST Analysis
4.2.5 Middle East and Africa PEST Analysis
4.3 Expert’s Opinion
5. Colorectal Cancer Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Increasing Prevalence of Colorectal Cancer
5.1.2 Launches of New Products
5.2 Key Restraints
5.2.1 Low Accuracy of Screening Based on Faecal Immunochemical Tests (FITs)
5.3 Opportunities
5.3.1 Growing Awareness of Colorectal Cancer
5.4 Future Trends
5.4.1 Artificial Intelligence in Colonoscopy
5.5 Impact Analysis
6. Colorectal Cancer Diagnostics Market – Global Analysis
6.1 Global Colorectal Cancer Diagnostics Market Revenue Forecast and Analysis
6.2 Global Colorectal Cancer Diagnostics Market, By Geography - Forecast and Analysis
6.3 Market Positioning of Key Players
7. Global Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by Modality
7.1 Overview
7.2 Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
7.3 Stool Based Tests
7.3.1 Overview
7.3.2 Stool Based Tests: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 Faecal Immunochemical Test (FIT)
7.3.3.1 Overview
7.3.3.2 Faecal Immunochemical Test (FIT): Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Guaiac-based Faecal Occult Blood Test (gFOBT)
7.3.4.1 Overview
7.3.4.2 Guaiac-based Faecal Occult Blood Test (gFOBT): Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Stool DNA Test
7.3.5.1 Overview
7.3.5.2 Stool DNA Test: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Imaging Tests
7.4.1 Overview
7.4.2 Imaging Tests: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Colonoscopy
7.4.3.1 Overview
7.4.3.2 Colonoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 CT Colonography
7.4.4.1 Overview
7.4.4.2 CT Colonography: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Flexible Sigmoidoscopy
7.4.5.1 Overview
7.4.5.2 Flexible Sigmoidoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.6 Capsule Endoscopy
7.4.6.1 Overview
7.4.6.2 Capsule Endoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4.7 Others
7.4.7.1 Overview
7.4.7.2 Others: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Global Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – by End User
8.1 Overview
8.2 Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
8.3 Hospitals
8.3.1 Overview
8.3.2 Hospitals: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Laboratories
8.4.1 Overview
8.4.2 Diagnostic Laboratories: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Cancer Research Institutes
8.5.1 Overview
8.5.2 Cancer Research Institutes: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Global Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 – Geographic Analysis
9.1 North America: Colorectal Cancer Diagnostics Market
9.1.1 Overview
9.1.2 North America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.3 North America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.3.1 North America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.3.2 North America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4 North America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.1 US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1.1 Overview
9.1.4.1.2 US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.1.3 US: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.1.3.1 US: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.1.3.2 US: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4.1.4 US: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.2 Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.2.1 Overview
9.1.4.2.2 Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.2.3 Canada: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.2.3.1 Canada: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.2.3.2 Canada: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.1.4.2.4 Canada: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.1.4.3 Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.1 Overview
9.1.4.3.2 Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.1.4.3.3 Mexico: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.1.4.3.3.1 Mexico: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.1.4.3.3.2 Mexico: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modalitys, 2020–2028 (US$ Million)
9.1.4.3.4 Mexico: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2 Europe: Colorectal Cancer Diagnostics Market
9.2.1 Overview
9.2.2 Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.3 Europe: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.3.1 Europe: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.3.2 Europe: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.4 Europe: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5 Europe: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
9.2.5.1 Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.1 Overview
9.2.5.1.2 Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.1.3 Germany: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.1.3.1 Germany: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.1.3.2 Germany: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.1.4 Germany: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.2 UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.1 Overview
9.2.5.2.2 UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.2.3 UK: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.2.3.1 UK: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.2.3.2 UK: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.2.4 UK: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.3 France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.1 Overview
9.2.5.3.2 France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.3.3 France: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.3.3.1 France: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.3.3.2 France: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.3.4 France: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.4 Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.1 Overview
9.2.5.4.2 Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.4.3 Italy: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.4.3.1 Italy: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.4.3.2 Italy: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.4.4 Italy: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.5 Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.1 Overview
9.2.5.5.2 Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.5.3 Spain: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.5.3.1 Spain: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.5.3.2 Spain: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.5.4 Spain: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.2.5.6 Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.1 Overview
9.2.5.6.2 Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.2.5.6.3 Rest of Europe: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.2.5.6.3.1 Rest of Europe: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.2.5.6.3.2 Rest of Europe: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.2.5.6.4 Rest of Europe: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3 Asia Pacific: Colorectal Cancer Diagnostics Market
9.3.1 Overview
9.3.2 Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.3 Asia Pacific: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.3.1 Asia Pacific: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.3.2 Asia Pacific: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4 Asia Pacific: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.1 China: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.1.1 Overview
9.3.4.1.2 China: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.1.3 China: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.1.3.1 China: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.1.3.2 China: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.1.4 China: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.2 Japan: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.2.1 Overview
9.3.4.2.2 Japan: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.2.3 Japan: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.2.3.1 Japan: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.2.3.2 Japan: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.2.4 Japan: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.3 India: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.3.1 Overview
9.3.4.3.2 India: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.3.3 India: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.3.3.1 India: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.3.3.2 India: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.3.4 India: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.4 Australia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.4.1 Overview
9.3.4.4.2 Australia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.4.3 Australia: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.4.3.1 Australia: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.4.3.2 Australia: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.4.4 Australia: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.5 South Korea: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.5.1 Overview
9.3.4.5.2 South Korea: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.5.3 South Korea: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.5.3.1 South Korea: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.5.3.2 South Korea: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.5.4 South Korea: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.3.4.6 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.6.1 Overview
9.3.4.6.2 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.3.4.6.3 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.3.4.6.3.1 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.3.4.6.3.2 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.3.4.6.4 Rest of Asia Pacific: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4 Middle East & Africa Colorectal Cancer Diagnostics Market
9.4.1 Overview
9.4.2 Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.3 Middle East & Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.3.1 Middle East & Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.3.2 Middle East & Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4 Middle East & Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.1 Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.1.1 Overview
9.4.4.1.2 Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.1.3 Saudi Arabia: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.1.3.1 Saudi Arabia: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.1.3.2 Saudi Arabia: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.1.4 Saudi Arabia Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.2 South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.2.1 Overview
9.4.4.2.2 South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.2.3 South Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.2.3.1 South Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.2.3.2 South Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.2.4 South Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.3 UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.3.1 Overview
9.4.4.3.2 UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.3.3 UAE: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.3.3.1 UAE: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.3.3.2 UAE: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.3.4 UAE Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.4.4.4 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.4.1 Overview
9.4.4.4.2 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4.4.4.3 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.4.4.4.3.1 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.4.4.4.3.2 Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.4.4.4.4 Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5 South & Central America Colorectal Cancer Diagnostics Market
9.5.1 Overview
9.5.2 South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.3 South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.3.1 South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.3.2 South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.4 South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5 South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
9.5.5.1 Brazil: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.1 Overview
9.5.5.1.2 Brazil: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.1.3 Brazil: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.1.3.1 Brazil: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.1.3.2 Brazil: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.5.1.4 Brazil: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5.2 Argentina: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.1 Overview
9.5.5.2.2 Argentina: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.2.3 Argentina: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.2.3.1 Argentina: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.2.3.2 Argentina: Colorectal Cancer Diagnostics Market, For Stool-Based Tests, 2020–2028 (US$ Million)
9.5.5.2.4 Argentina: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
9.5.5.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.1 Overview
9.5.5.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5.5.3.3 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by Modality, 2020–2028 (US$ Million)
9.5.5.3.3.1 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality, 2020–2028 (US$ Million)
9.5.5.3.3.2 Rest of South & Central America: Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality, 2020–2028 (US$ Million)
9.5.5.3.4 Rest of South & Central America: Colorectal Cancer Diagnostics Market, by End User, 2020–2028 (US$ Million)
10. Impact of COVID-19 Pandemic on Colorectal Cancer Diagnostics Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Global Colorectal Cancer Diagnostics Market–Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Colorectal Cancer Diagnostics Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Medtronic Plc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Illumina Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Clinical Genomics Technologies Pty Ltd
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 EDP Biotech Corp
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Epigenomics AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 F. Hoffmann-La Roche Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Quest Diagnostics Inc
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Novigenix SA
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Siemens Healthineers AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Bruker Corp
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
12.11 Eiken Chemical Co., Ltd.
12.11.1 Key Facts
12.11.2 Business Description
12.11.3 Products and Services
12.11.4 Financial Overview
12.11.5 SWOT Analysis
12.11.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 2. North America Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 3. North America Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 4. North America Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 5. US Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 6. US Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 7. US Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 8. US Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 9. Canada Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 10. Canada Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 11. Canada Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 12. Canada Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 13. Mexico Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 14. Mexico Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 15. Mexico Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modalitys– Revenue and Forecast to 2028 (US$ Million)
Table 16. Mexico Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 17. Europe Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 18. Europe Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 19. Europe Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 20. Europe Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 21. Screening approach for colorectal cancer followed in Germany is mentioned in the given Table:
Table 22. Germany Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 23. Germany Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 24. Germany Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 25. Germany Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 26. UK Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 27. UK Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 28. UK Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 29. UK Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 30. France Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 31. France Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 32. France Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 33. France Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 34. Italy Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 35. Italy Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 36. Italy Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 37. Italy Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 38. Spain Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 39. Spain Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 40. Spain Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 41. Spain Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 42. Rest of Europe Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 43. Rest of Europe Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 44. Rest of Europe Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 45. Rest of Europe Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 46. Asia Pacific Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 47. Asia Pacific Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 48. Asia Pacific Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 49. Asia Pacific Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 50. China Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 51. China Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 52. China Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 53. China Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 54. Japan Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 55. Japan Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 56. Japan Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 57. Japan Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 58. India Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 59. India Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 60. India Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 61. India Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 62. Australia Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 63. Australia Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 64. Australia Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 65. Australia Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 66. South Korea Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 67. South Korea Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 68. South Korea Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 69. South Korea Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 70. Rest of Asia Pacific Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 71. Rest of Asia Pacific Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 72. Rest of Asia Pacific Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 73. Rest of Asia Pacific Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 74. Middle East & Africa Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 75. Middle East & Africa Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 76. Middle East & Africa Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 77. Middle East & Africa Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 78. Saudi Arabia Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 79. Saudi Arabia Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 80. Saudi Arabia Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 81. Saudi Arabia Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 82. South Africa Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 83. South Africa Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 84. South Africa Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 85. South Africa Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 86. UAE Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 87. UAE Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 88. UAE Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 89. UAE Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 90. Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 91. Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 92. Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 93. Rest of Middle East & Africa Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 94. South & Central America Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 95. South & Central America Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 96. South & Central America Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 97. South & Central America Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 98. Brazil Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 99. Brazil Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 100. Brazil Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 101. Brazil Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 102. Argentina Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 103. Argentina Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 104. Argentina Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 105. Argentina Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 106. Rest of South & Central America Colorectal Cancer Diagnostics Market, by Modality – Revenue and Forecast to 2028 (US$ Million)
Table 107. Rest of South & Central America Colorectal Cancer Diagnostics Market, For Imaging Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 108. Rest of South & Central America Colorectal Cancer Diagnostics Market, For Stool Based Tests by Modality– Revenue and Forecast to 2028 (US$ Million)
Table 109. Rest of South & Central America Colorectal Cancer Diagnostics Market, by End User – Revenue and Forecast to 2028 (US$ Million)
Table 110. Recent Inorganic Growth Strategies in the colorectal cancer diagnostics Market
Table 111. Recent Organic Growth Strategies in the Colorectal Cancer Diagnostics Market
Table 112. Glossary of Terms
LIST OF FIGURES
Figure 1. Colorectal Cancer Diagnostics Market Segmentation
Figure 2. Colorectal Cancer Diagnostics Market, by Region
Figure 3. Global Colorectal Cancer Diagnostics Market Overview
Figure 4. Imaging Tests Segment Held Largest Share of Modality Segment in Colorectal Cancer Diagnostics Market
Figure 5. Asia Pacific Expected to Show Remarkable Growth During Forecast Period
Figure 6. Colorectal Cancer Diagnostics Market, by Geography (US$ Million)
Figure 7. Global Colorectal Cancer Diagnostics Market – Leading Country Markets (US$ Million)
Figure 8. Global Colorectal Cancer Diagnostics Market – Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. South and Central America: PEST Analysis
Figure 13. Middle East and Africa: PEST Analysis
Figure 14. Experts’ Opinion
Figure 15. Colorectal Cancer Diagnostics Market Impact Analysis of Driver and Restraints
Figure 16. Global Colorectal Cancer Diagnostics Market – Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Colorectal Cancer Diagnostics Market – By Geography Forecast and Analysis – 2023- 2028
Figure 18. Market Positioning of Key Players in Global Colorectal Cancer Diagnostics Market
Figure 19. Colorectal Cancer Diagnostics Market Revenue Share, by Modality 2022 & 2028 (%)
Figure 20. Stool Based Tests: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Faecal Immunochemical Test (FIT): Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Guaiac-based Faecal Occult Blood Test (gFOBT): Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Stool DNA Test: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Imaging Tests: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Colonoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. CT Colonography: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Flexible Sigmoidoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Capsule Endoscopy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. Others: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 30. Colorectal Cancer Diagnostics Market Revenue Share, by End User 2022 & 2028 (%)
Figure 31. Hospitals: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 32. Diagnostic Laboratories: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 33. Cancer Research Institutes: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 34. Others: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 35. North America: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 36. North America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 37. North America: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 38. US: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 39. Canada: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 40. Mexico: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 41. Europe: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 42. Europe Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 43. Europe: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 44. Germany: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 45. UK: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 46. France: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 47. Italy: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 48. Spain: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 49. Rest of Europe: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 50. Asia Pacific: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 51. Asia Pacific Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 52. Asia Pacific: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 53. China: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 54. Japan: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 55. India: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 56. Australia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 57. South Korea: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 58. Rest of Asia Pacific: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 59. Middle East & Africa: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 60. Middle East & Africa Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 61. Middle East & Africa: Colorectal Cancer Diagnostics Market, by Country, 2022 & 2028 (%)
Figure 62. Saudi Arabia: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 63. South Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 64. UAE: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 65. Rest of Middle East & Africa: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 66. South & Central America: Colorectal Cancer Diagnostics Market, by Key Country – Revenue (2022) (US$ Million)
Figure 67. South & Central America Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 68. South & Central America: Colorectal Cancer Diagnostics Market, by country, 2022 & 2028 (%)
Figure 69. Brazil: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 70. Argentina: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 71. Rest of South & Central America: Colorectal Cancer Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 72. Impact of COVID-19 Pandemic on North American Country Markets
Figure 73. Impact of COVID-19 Pandemic in European Country Markets
Figure 74. Impact of COVID-19 Pandemic on Asia Pacific Country Markets
Figure 75. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 76. Impact of COVID-19 Pandemic on South & Central America Country Markets
Figure 77. Growth Strategies in the Colorectal Cancer Diagnostics Market
The List of Companies - Colorectal Cancer Diagnostics Market
- Medtronic Plc
- Illumina Inc
- Clinical Genomics Technologies Pty Ltd
- EDP Biotech Corp
- Epigenomics AG
- F. Hoffmann-La Roche Ltd
- Quest Diagnostics Inc
- Novigenix SA
- Siemens Healthineers AG
- Bruker Corp
- Eiken Chemical Co., Ltd.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Colorectal Cancer Diagnostics Market
May 2023
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
May 2023
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
May 2023
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
May 2023
Electronic Patient-Reported Outcomes (ePROS) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Delivery Mode (Cloud Based and On-Premises), Application (Oncology, Respiratory, and Others), End User [Contract Research Organizations (CROs), Pharmaceutical Companies, and Others], and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2023
Wellbeing Platform Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service (Health Risk Assessment, Fitness, Smoking Cessation, Health Screening, Nutrition & Weight Management, Stress Management, Comprehensive Wellbeing, and Others), Category (Fitness & Nutrition Consultant, Psychological Therapists, and Organization/Employers), Delivery Model (Onsite and Offsite), End User (Small-Scale Organizations, Medium-Scale Organizations, Large-Scale Organization, and Homecare), and Geography
May 2023
Smart Hospital Beds Market
Size and Forecast (2020–2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Patient Weight (Less than 70 lb, 70 to 150 lb, 150 to 400 lb, 400 to 500 lb, Greater than 500 lb); Offering (Products and Accessories, Software and Solutions, and Services); Application (Fall Prevention, Pressure Injury Prevention, Patient Deterioration and Monitoring, and Others); End User (Hospitals, Clinics and Nursing Homes, Ambulatory Surgical Centers, Medical Laboratories, Long Term Care Centers, and Others), and Geography
Get Free Sample For